Legal basis: Article 3 of the Drug Administration Law of People's Republic of China (PRC).
Drug management should focus on people's health, adhere to the principles of risk management, whole process control and social co-governance, establish a scientific and strict supervision and management system, comprehensively improve drug quality, and ensure drug safety, effectiveness and accessibility. Article 4 The state develops modern medicine and traditional medicine and gives full play to their roles in prevention, medical treatment and health care. The state protects wild medicinal resources and varieties of traditional Chinese medicine, and encourages the cultivation of genuine medicinal materials. Article 5 The State encourages the research and development of new drugs and protects the legitimate rights and interests of citizens, legal persons and other organizations in the research and development of new drugs. Article 6 The State implements the drug marketing license holder system for drug administration. The holder of the drug marketing license is responsible for the safety, effectiveness and quality controllability of the whole process of drug research and development, production, management and use according to law. Article 7 In the research and development, production, marketing and use of drugs, laws, regulations, rules, standards and norms shall be observed to ensure the truthfulness, accuracy, completeness and traceability of the information in the whole process. Article 8 The drug supervision and administration department of the State Council is in charge of drug supervision and administration throughout the country. The relevant departments of the State Council are responsible for drug supervision and administration within their respective functions and duties. The drug supervision and administration department of the State Council cooperates with the relevant departments of the State Council to implement the national drug industry development plan and industrial policy.